Member access

4-Traders Homepage  >  Shares  >  Nyse  >  The Procter & Gamble Company    PG   US7427181091

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Analysis summary4-Traders Strategies 

The Procter & Gamble Company : A lot of downside potential

06/26/2012 | 11:56am
Opinion : Bearish under 61 USD
Target price : 56.9 USD
Stop loss: 56.9 USD
NYSE
Household Products
The Procter & Gamble Company is focused on providing consumer packaged goods. The company’s products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high-frequency stores, the neighborhood stores, which serve many consumers in developing markets. As of June 30, 2011, P&G was organized into six segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care.

On June 20th, P&G lowered its earnings guidance for the current quarter and for the fiscal year 2013 for the second time in two months because of slowing demand in Europe and China and the negative impact from foreign exchange rates.

From a fundamental viewpoint, Procter & Gamble is very expansive for a large and mature company. It is currently trading 16.2 times its 2012 EPS estimated and it has an EV/EBITDA of 10.2x. Growth rate for the coming years are low. Leverage is high with almost USD 30 million of debt. Besides, analysts decreased constantly their EPS and revenues estimates for 2012 and 2013.

Technically, the security is in a downward trend. All moving averages have a bearish configuration. Few days ago, there was a huge gap because of the announcement and this trend may continue in the coming days towards the USD 56.9 support.

Therefore, a potential decline is suggested by weak fundamentals and graphical analysis. Investors should take a short position immediately. The target price is USD 56.9. To avoid important losses, a stop loss will be fixed in the USD 61 area.
The Procter & Gamble Company : The Procter & Gamble Company : A lot of downside potential
Copyright (c) 2013 4-Traders.com



Partner Area
React to this article
 

Disclaimer : 4-Traders.com is not registered as a securities broker-dealer or investment adviser with any jurisdiction and is not providing any personalized financial, investment or tax advice. 4-Traders cannot assess or guarantee the suitability of any particular investment to any personal situation. Accordingly, you bear complete responsibility for your own investment, financial, and tax research and decisions and should seek the advice of a qualified professional prior to making any decisions based on 4-Traders' website information. This article is provided solely for informational purposes, and does not constitute an offer or solicitation to buy or sell any securities. All opinions expressed and information and data provided therein are subject to change without notice.

Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 216 768 M$ -
Company Value 242 698 M$ 241 935 M$
Valuation 2013e 2014e
PER (Price / EPS) 19,6x 18,5x
Capitalization / Revenue 2,58x 2,49x
EV / Revenue 2,88x 2,78x
EV / EBITDA 12,8x 11,9x
Yield (DPS / Price) 2,88% 3,14%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 18,9% 19,6%
operating laverage (Delta EBIT / Delta Sales) 22,9x 2,29x
Net Margin (Net Profit / Revenue) 13,9% 14,2%
ROA (Net Profit / Asset) 8,72% 8,88%
ROE (Net Profit / Equities) 18,0% 18,6%
Rate of Dividend 56,7% 58,2%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   4,65% 4,60%
Cash Flow / Sales (Taux d'autofinancement) 16,6% 17,2%
Capital Intensity (Assets / Sales) 1,60x 1,60x
Financial Leverage (Net Debt / EBITDA) 1,36x 1,24x
Income Statement Evolution
The Procter _ Gamble Compa : Income Statement Evolution
More Financials
EPS Revisions
The Procter _ Gamble Compa : EPS Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.